Skadden advised Eyebiotech Limited, while Gibson, Dunn & Crutcher advised Merck the deal. Merck, known as MSD outside of the United States and Canada, and Eyebiotech...
Merck’s Acquisition of Eyebiotech
Luminance’s $40 Million Series B Funding Round
Gibson, Dunn & Crutcher advised March Capital on the transaction. Luminance, the leader in ‘legal-grade’ AI, announced that it raised $40 million in a Series B funding...
NTWRK’s Acquisition of Complex
Gibson, Dunn & Crutcher LLP represented NTWRK in its acquisition of publisher Complex from BuzzFeed. NTWRK, the premium live-video shopping platform and curated marketplace serving buyers...
Essential AI’s $56.5 Million Capital Raise
Gibson, Dunn & Crutcher LLP advised Essential AI on the capital raise. Essential AI has raised a $56.5 million Series A funding round led by March...
Eridan Communications’ US$46 Million Series B Funding
O’Melveny represented Eridan Communications, Inc. on the deal. Eridan Communications, Inc., a 5G radio manufacturer that specializes in wireless connectivity infrastructure development, announced its US$46 million Series...
Menlo Microsystems’ US$150 Million Funding Round
O’Melveny represented Menlo Microsystems on the deal. Menlo Microsystems, Inc., the company responsible for reinventing the electronic switch with its Ideal Switch™ technology, announced its US$150 million...